Table 3.
Barriers for patient reporting of ADRs
Author (year), country | Poor awareness | Confusion as to who reports ADRs, and to whom | Difficulty with ADR reporting procedures and forms | ADRs resolved | Lack of feedback on submitted ADR | Mailing cost | Prior negative experience |
---|---|---|---|---|---|---|---|
Aljadhey and Albogami (2013) 12 , Saudi Arabia | 87% | 80% | |||||
Arnott et al. (2013) 20 , UK | √ | √ | √ | ||||
Avery et al. (2011) 13 , UK | 74% | √ | 15.9% | √ | √ | ||
Braun et al. (2010) 21 , Australia | √ | √ | √ | ||||
Bukirwa et al. (2008) 22 , Uganda | √ | √ | √ | ||||
Elkalmi et al. (2013) 14 , Malaysia | 65.6% | ||||||
Gujral and Cairns (2010) 32 UK | √ | √ | |||||
Jha et al. (2014) 23 Nepal | √ | √ | √ | √ | |||
Krska et al. (2011) 15 UK | 93.8% | ||||||
Lebanova et al. (2014) 16 , Bulgaria | 78.7% | √ | |||||
Lorimer et al. (2012) 19 UK | √ | √ | √ | √ | |||
Matos et al. (2014) 17 , Portugal | 44% | √ | |||||
Parrella et al. (2014) 33 Australia | √ | ||||||
Robertson and Newby (2013) 18 , Australia | 89.7% | √ | |||||
Salvo et al. (2013) 35 , Italy | √ | ||||||
Total | 14 | 8 | 4 | 5 | 2 | 2 | 1 |
ADR, adverse drug reaction